Bogart Wealth LLC
RXRX icon

Bogart Wealth LLC’s Recursion Pharmaceuticals RXRX Stock Holding History

Bogart Wealth LLC’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$139 Hold
38
– – ﹤0.01% 1921
2026
Q1 		$117 Hold
38
– – ﹤0.01% 1733
2025
Q4 		$155 Sell
38
-4,000
-99% -$19.8K ﹤0.01% 1543
2025
Q3 		$19.7K Buy
4,038
+4,000
+10,526% +$21K ﹤0.01% 668
2025
Q2 		$192 Hold
38
– – ﹤0.01% 1407
2025
Q1 		$201 Buy
+38
New +$277 ﹤0.01% 1355

Other funds holding RXRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bogart Wealth LLC's RXRX Position: Q2 2026 in Review

Bogart Wealth LLC held its Recursion Pharmaceuticals (RXRX) position steady in Q2 2026 at 38 shares worth $139. The position accounts for ﹤0.01% of the portfolio, ranked #1921.

Bogart Wealth LLC first reported a position in RXRX in Q1 2025 and has held it in 6 quarters since. The position peaked at $19.7K in Q3 2025. 343 funds tracked by Wall St. Rank hold RXRX as of Q2 2026.

  • Bogart Wealth LLC held 38 shares of Recursion Pharmaceuticals worth $139 as of Q2 2026.
  • Bogart Wealth LLC left its Recursion Pharmaceuticals share count unchanged in Q2 2026.
  • Recursion Pharmaceuticals made up ﹤0.01% of Bogart Wealth LLC's portfolio in Q2 2026, its #1921 holding.
  • Bogart Wealth LLC first reported a position in Recursion Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Bogart Wealth LLC's Recursion Pharmaceuticals position peaked at $19.7K in Q3 2025.
  • 343 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2026.

Based on Bogart Wealth LLC's 13F filing for Q2 2026, filed 24 Jul 2026.